Gaush Meditech Ltd. (HK:2407) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Gaush Meditech Ltd announced successful shareholder approval of all proposed resolutions at their Annual General Meeting held on May 30, 2024, including the adoption of audited financial statements, a final dividend declaration, director re-elections, and the re-appointment of Ernst & Young as auditor. Notably, the resolutions were passed with an overwhelming majority, highlighting shareholder confidence in the company’s leadership and financial health.
For further insights into HK:2407 stock, check out TipRanks’ Stock Analysis page.